Recalls & Warnings December 19, 2012 Zicam Nasal Gel Recalled Due to Potential Bacterial Contamination On December 18, 2012, Matrixx Initiatives issued a voluntary recall of a single lot of Zicam Extreme Congestion Relief nasal gel after routine testing confirmed a sample from this lot was contaminated with Burkholderia cepacia
In studies where beta-3 receptors were genetically deleted, the peptide lost its fat-reducing effects, confirming this pathways critical role
This gentler approach reduces foaming and ensures even wetting of the powder
Quick intake, quick delivery, and meds were well packaged
Because it is largely free of those binding proteins, the analog stays active far longer than native IGF-1 a substantially extended half-life and more sustained systemic exposure
Research further documents measurable reductions in oxidative stress markers within joint tissue following peptide administration